All In Biotech

Drug Trial Radar · NCT05696886

The Effect of Intraoperative Tramadol on Postoperative Opioid

The Effect of Intraoperative Tramadol on Postoperative Opioid Requirements After Laparoscopic Sleeve Gastrectomy for Morbid Obese Patients (A Retrospective Multicentric Cohort Study)

Last checked: Nov 20, 2026Latest source record: Jan 25, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

400

Actual

Start

Jan 1, 2021

Primary completion

Dec 31, 2022

Study completion Dec 31, 2022

Sponsor

Lead sponsor
Mansoura UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jan 25, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 16 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Postoperative pain remains a very UNPLEASENTevent, particularly in morbidly obese patients that may be associated with obstructive sleep apnea. Bariatric surgery patients must get safe and efficient analgesia, which is essential given that up to 45 % of patients report substantial pain in the first two days following surgery. The study's purpose was to compare the efficacy and safety of combined tramadol with pethidine versus pethidine alone and to assess their impact on postoperative pethidine requirements after LSG for morbidly obese patients

Conditions

  • Postoperative Pain

Interventions

  • PethidineDrug

    Group A received Pethidine alone in the period between January 2021 and December 2021

  • Tramadol with pethidineDrug

    Group B got Tramadol with pethidine in the period between January 2022 and December 2022

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. VAS of painTime frame: 48 hours postoperative
  2. opioid requirementTime frame: one month

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Ayman El Nakeeb

    Al Mansurah, Outside U.S and Canada, Egypt

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.